BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2033426)

  • 1. Is more better? Dose intensity in neuroblastoma.
    Anderson JR; Coccia PF
    J Clin Oncol; 1991 Jun; 9(6):902-4. PubMed ID: 2033426
    [No Abstract]   [Full Text] [Related]  

  • 2. Carboplatin activity in cisplatin treated neuroblastoma.
    Lewis IJ; Stevens MC; Pearson AD; Pinkerton CR; Barnes JM
    Prog Clin Biol Res; 1991; 366():553-9. PubMed ID: 2068173
    [No Abstract]   [Full Text] [Related]  

  • 3. A single center experience with bone marrow transplantation for high risk neuroblastoma.
    Ladenstein R; Lasset C; Bouffet E; Brunat-Mentigny M; Biron P; Philip I; Chauvin F; Philip T
    Bone Marrow Transplant; 1991; 7 Suppl 2():93. PubMed ID: 1878741
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.
    Cheung NV; Heller G
    J Clin Oncol; 1991 Jun; 9(6):1050-8. PubMed ID: 2033419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
    Pritchard J; Whelan R; Hill BT
    Prog Clin Biol Res; 1985; 175():545-55. PubMed ID: 4039448
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.
    Shafford EA; Rogers DW; Pritchard J
    J Clin Oncol; 1984 Jul; 2(7):742-7. PubMed ID: 6539811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of cis-dichlorodiammine-platinum in the treatment of advanced neuroblastoma].
    Ohnuma N; Takahashi H; Maie M; Etoh T; Tanabe M; Kuriyama Y
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2876-80. PubMed ID: 3662544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
    Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
    J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Megatherapy" for advanced neuroblastoma--rationale and role.
    Pritchard J
    Eur J Cancer; 1995; 31A(2):134-6. PubMed ID: 7718315
    [No Abstract]   [Full Text] [Related]  

  • 13. Rethinking management of localized neuroblastoma.
    Kushner BH; LaQuaglia MP; Cheung NK
    J Clin Oncol; 1993 Sep; 11(9):1832-4. PubMed ID: 8257505
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
    Lam-Po-Tang PR; McCowage GB; Vowels MR
    Transplant Proc; 1993 Oct; 25(5):2881-2. PubMed ID: 8212272
    [No Abstract]   [Full Text] [Related]  

  • 16. Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patients.
    Zucker JM; Philip T; Bernard JL; Michon J; Bouffet E; Gentet JC; Lopez M; Coze C; Philip I
    Bone Marrow Transplant; 1991; 7 Suppl 2():91. PubMed ID: 1878739
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of A 1 protocol in advanced neuroblastoma].
    Iwafuchi M; Ohsawa Y; Hirota M; Matsuda Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1323-8. PubMed ID: 2730045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
    Kushner BH; LaQuaglia MP; Bonilla MA; Lindsley K; Rosenfield N; Yeh S; Eddy J; Gerald WL; Heller G; Cheung NK
    J Clin Oncol; 1994 Dec; 12(12):2607-13. PubMed ID: 7527454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
    J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma in an adolescent girl.
    Kannan R; Varma S; Ramprakash B; Nadaradjan S; Jeyaraman S; Sundararaman T; Sethuraman KR
    J Assoc Physicians India; 2001 Apr; 49():490-1. PubMed ID: 11762629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.